Scandinavian Medical Solutions AS (OCSE:SMSMED) ROCE %: -21.15% (As of Mar. 2026)


OCSE:SMSMED Scandinavian Medical Solutions AS OCSE:SMSMED
81 GF Score
Price kr2.90
GF Value kr6.23
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Scandinavian Medical Solutions AS ROCE %?

Scandinavian Medical Solutions AS OCSE:SMSMED -0.34% 81 ROCE % is -21.15% as of Mar. 2026. GuruFocus rates OCSE:SMSMED with a GF Score™ of 81/100 and a GF Value™ of kr6.23 (Possible Value Trap). The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Scandinavian Medical Solutions AS's annualized ROCE % for the quarter that ended in Mar. 2026 was -21.15%.

Scandinavian Medical Solutions AS  (OCSE:SMSMED) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Scandinavian Medical Solutions AS ROCE % Related Terms

Scandinavian Medical Solutions AS ROCE % Historical Data

* Premium members only.

The historical data trend for Scandinavian Medical Solutions AS's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scandinavian Medical Solutions AS ROCE % Chart

Scandinavian Medical Solutions AS Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
ROCE %
Get a 7-Day Free Trial 76.42 33.29 21.24 16.20 2.24

Scandinavian Medical Solutions AS Semi-Annual Data
Sep19 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.32 22.14 -3.54 7.45 -21.15
OCSE:SMSMED
81GF Score
Scandinavian Medical Solutions AS OCSE:SMSMED
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scandinavian Medical Solutions AS ROCE % Calculation

Scandinavian Medical Solutions AS's annualized ROCE % for the fiscal year that ended in Sep. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Sep. 2025 )  (A: Sep. 2024 )(A: Sep. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Sep. 2025 )  (A: Sep. 2024 )(A: Sep. 2025 )
=2.366/( ( (174.115 - 77.334) + (205.858 - 91.026) )/ 2 )
=2.366/( (96.781+114.832)/ 2 )
=2.366/105.8065
=2.24 %

Scandinavian Medical Solutions AS's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=-23.552/( ( (205.858 - 91.026) + (196.673 - 88.769) )/ 2 )
=-23.552/( ( 114.832 + 107.904 )/ 2 )
=-23.552/111.368
=-21.15 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -21.15% mean?
Scandinavian Medical Solutions AS (OCSE:SMSMED) has a ROCE % of -21.15% as of Mar. 2026.
Is Scandinavian Medical Solutions AS's ROCE % too high?
Scandinavian Medical Solutions AS's current ROCE % is -21.15%. Overall, Scandinavian Medical Solutions AS has a GF Score™ of 81/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Scandinavian Medical Solutions AS's ROCE % compare to ABT and SYK?
Scandinavian Medical Solutions AS's ROCE % of -21.15% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scandinavian Medical Solutions AS's current ROCE % is -21.15%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scandinavian Medical Solutions AS stock overvalued right now?
Based on GuruFocus' analysis, Scandinavian Medical Solutions AS (OCSE:SMSMED) is currently considered Possible Value Trap. The stock's GF Value™ is kr6.23, compared to a current price of kr2.90 — trading 53.5% below its estimated fair value. The current ROCE % is -21.15%. Scandinavian Medical Solutions AS's overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Scandinavian Medical Solutions AS (OCSE:SMSMED), the current ROCE % is -21.15% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scandinavian Medical Solutions AS (OCSE:SMSMED) Overvalued in 2026?

Based on GuruFocus' analysis, Scandinavian Medical Solutions AS stock appears to be undervalued. The current stock price of kr2.90 is trading 53.5% below its estimated GF Value™ of kr6.23. GuruFocus considers Scandinavian Medical Solutions AS to be Possible Value Trap.

Key valuation signals for OCSE:SMSMED:

  • ROCE %: -21.15%
  • GF Value™: kr6.23 vs. price of kr2.90 (53.5% below fair value)
  • GF Score™: 81/100 with 7 warning signs

No single metric tells the full story. See the OCSE:SMSMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Scandinavian Medical Solutions AS Business Description

Other Exchanges K41:Germany
Address Gasvaerksvej 48, 1st Floor, Aalborg, DNK, 9000
Scandinavian Medical Solutions AS is a provider of Medical Imaging equipment. The company specializes in the acquisition, quality check, and resale of high-quality pre-owned medical imaging systems. The company supplies value-added resellers and distributors in various countries with MRI, CT, PET/CT, and other diagnostic scanners. It operates the business through three business areas, Equipment Solutions, Parts Solutions and Rental Solutions. Equipment Solutions is the company's main source of revenue, which focuses on sourcing, inspecting, and selling imaging systems such as MRI, CT, PET/CT, Cath-Lab, and Mammography units.
81GF Score

Get the complete analysis for OCSE:SMSMED

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.90
Price
kr6.23
GF Value